Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Memory loss sits at the center of this dementia and brain health question.
When a loved one starts forgetting important dates or struggles to follow conversations, a doctor won’t rely on observation alone to determine the cause. Instead, they’ll order a series of diagnostic tests designed to evaluate memory loss and identify its underlying cause. These tests range from simple blood work to advanced imaging that can reveal structural changes in the brain. The goal is straightforward: gather enough information to distinguish between normal aging, reversible conditions like thyroid problems, and true cognitive decline like Alzheimer’s disease or other forms of dementia.
Consider someone in their late sixties who’s been having trouble remembering recent conversations—forgetting where they parked the car or repeating the same story twice in an evening. Their doctor doesn’t immediately diagnose them with dementia. Instead, the doctor orders blood tests to check thyroid function and vitamin B12 levels, because these conditions can perfectly mimic memory loss but are completely treatable. Only if those tests come back normal might an MRI be ordered to look at the brain’s structure, followed by cognitive testing to measure the extent of any impairment.
Table of Contents
- What Blood Tests Reveal About Memory Loss
- Neuroimaging—Seeing Inside the Brain
- Cognitive Testing—Measuring Decline
- Building a Complete Picture—How Doctors Decide What to Order
- The Role of Family History and Emerging Biomarker Tests
- What the Tests Can and Cannot Tell You
- What to Expect Going Forward
- Conclusion
What Blood Tests Reveal About Memory Loss
Blood tests form the foundation of memory loss evaluation because they can identify several treatable conditions that damage cognition. A Complete Blood Count (CBC) screens for anemia and infection, while a Comprehensive Metabolic Panel (CMP) checks how well the liver and kidneys function—both can affect mental clarity if they’re not working properly. Thyroid Stimulating Hormone (TSH) testing is particularly important because an underactive or overactive thyroid can produce memory problems, fatigue, and confusion that look exactly like early dementia, yet are easily managed with medication.
vitamin B12 deficiency deserves special attention because it causes a specific type of cognitive damage that worsens the longer it goes untreated. A person with low B12 might experience memory loss, confusion, and difficulty concentrating, but adding B12 supplements can reverse these symptoms if caught early enough. The blood test itself is straightforward, but its implications are significant—this is why every memory loss workup includes it. Additionally, screening for syphilis (Rapid Plasma Reagin or RPR) and HIV testing may be ordered, as both infections can affect the brain and produce cognitive symptoms that respond to treatment.
Neuroimaging—Seeing Inside the Brain
Magnetic Resonance Imaging (MRI) is considered one of the most useful tests in a dementia workup because it produces detailed, three-dimensional images of the brain’s structure. Unlike a CT scan, which uses radiation and produces less detailed images, an MRI uses magnetic fields to create a clear picture of brain tissue. This image can reveal tumors, infections, areas of stroke, fluid accumulation, or brain atrophy—all of which can cause or contribute to memory loss. For someone with symptoms that started suddenly or who’s had recent head trauma, an MRI might be the first imaging test ordered. A significant limitation of MRI is cost and accessibility.
The test can run several hundred dollars even with insurance, and not every facility has an MRI machine available immediately. In some cases, patients wait weeks for appointments. Additionally, MRI scans cannot definitively diagnose Alzheimer’s disease or most other dementias just by looking at the brain—they’re better at ruling out structural problems that might be causing the symptoms. A person can have a completely normal MRI and still have moderate cognitive decline from Alzheimer’s disease. This is why MRI is typically used alongside other tests rather than as a standalone diagnostic tool.
Cognitive Testing—Measuring Decline
Psychometric tests are standardized written and verbal exercises that measure how quickly and accurately a person can process information, remember words, and solve problems. During these tests, a patient might be asked to repeat a list of words, draw a clock, identify objects in pictures, or perform simple arithmetic. These tests aren’t designed to trick anyone—they’re carefully validated tools that decades of research have shown can differentiate between normal aging and genuine cognitive impairment. A person without dementia typically performs differently than someone in early stages of cognitive decline.
One common example is the Montreal Cognitive Assessment (MoCA) or Mini-Cog test, which takes 10 to 15 minutes and screens for multiple types of cognitive problems. If someone scores low on these initial screenings, more extensive neuropsychological testing may be ordered, which can take several hours and is administered by a psychologist specializing in memory disorders. The advantage of thorough cognitive testing is precision—it can show which specific abilities are affected and which remain intact, helping guide both diagnosis and treatment planning. Family members are often asked to provide input during these assessments, describing how the person’s functioning has changed in daily life compared to five years ago or a decade ago.
Building a Complete Picture—How Doctors Decide What to Order
Doctors don’t order every available test for every patient. Instead, they start with a detailed conversation about when symptoms began, how they’ve progressed, family history of dementia or neurological disease, medications the person takes, and how the symptoms affect daily life. They perform a physical exam including neurological testing to check reflexes, balance, and strength. This information guides which tests are actually needed.
A 58-year-old with sudden memory loss and a family history of Huntington’s disease follows a different testing pathway than a 78-year-old with gradual decline and a family history of Alzheimer’s disease. The practical tradeoff is between thoroughness and practical reality. A comprehensive memory loss workup might include 8 to 10 different tests, adding up to hundreds or thousands of dollars, weeks of appointments, and potential false positives that create unnecessary anxiety. Good clinical practice means ordering tests that will meaningfully change how the doctor manages the situation—testing thyroid function because it’s treatable, ordering MRI if there’s a concern about stroke or tumor, but not automatically ordering every specialized brain imaging study available. Some doctors work with memory care specialists or neurologists who focus specifically on dementia and have developed expertise in determining which tests add real diagnostic value.
The Role of Family History and Emerging Biomarker Tests
Family history matters because genetic factors influence dementia risk. Someone whose mother and grandfather both had Alzheimer’s disease faces different probabilities than someone with no family history, and this shapes which tests are prioritized. The presence of the APOE4 gene, which can be identified through blood tests, increases Alzheimer’s risk—though having the gene doesn’t guarantee someone will develop dementia. Genetic counseling helps families understand what these findings mean.
A major development came in April 2025 when new blood and spinal fluid biomarker tests emerged that detect the biological mechanisms of memory loss and Alzheimer’s disease rather than just imaging changes. These tests look for specific proteins like phosphorylated tau and amyloid-beta in the bloodstream, providing information about whether Alzheimer’s pathology is actually present in the brain. A critical warning: these newer biomarker tests are rapidly evolving, their interpretation is still being refined, and they’re not yet standard in all clinical settings. Some people might receive results they don’t fully understand without proper counseling about what the findings mean for their future. The advantage is earlier detection and the possibility of starting treatments before significant cognitive decline occurs, but the limitation is that these tests raise important questions about how to manage people with biomarker evidence of disease but no symptoms yet.
What the Tests Can and Cannot Tell You
Memory loss workups are excellent at ruling certain things out. A normal blood test rules out B12 deficiency, thyroid problems, and obvious infection. A normal MRI rules out tumors, strokes, and fluid buildup. Normal cognitive testing in the context of normal imaging and normal blood work suggests that the reported memory loss might be age-appropriate forgetfulness rather than pathological decline. For someone worried they’re developing dementia, hearing that major treatable and dangerous conditions have been excluded provides real reassurance.
However, these tests cannot predict the future. A normal workup today doesn’t guarantee someone won’t develop cognitive problems in five years. The tests show what’s happening now, not what will happen next. Someone with biomarker evidence of Alzheimer’s-type pathology might remain cognitively normal for another decade, or their symptoms might progress rapidly—current tests cannot make that prediction with certainty. This is why doctors often recommend repeat evaluations periodically if cognitive concerns persist, and why family observation over time is as important as any single test.
What to Expect Going Forward
The landscape of memory loss testing is changing rapidly. Biomarker tests that once required spinal fluid samples are now available as blood tests, making screening simpler and less invasive. As these tools become more standardized and insurance coverage expands, more people may be offered early detection testing before symptoms appear. This represents a shift from diagnosing dementia after cognitive decline is obvious to identifying pathology early when interventions might prevent or delay symptoms.
However, this shift brings new challenges around interpretation and anxiety. Patients need clear counseling about what test results mean, what they don’t mean, and what the next steps should be. Families should expect their doctor to explain not just what tests are being ordered but why—what question each test is answering, what would change the management if the results came back abnormal, and what won’t change regardless of results. Good memory loss evaluation combines rigorous testing with thoughtful clinical judgment.
Conclusion
Memory loss workup tests serve one essential function: gathering information to guide diagnosis and treatment decisions. Blood tests screen for treatable conditions, MRI imaging rules out structural problems, cognitive testing measures functional decline, and emerging biomarker tests reveal the biological underpinnings of cognitive disease. The specific combination of tests ordered should be tailored to the individual’s presentation and the clinical questions being asked, not applied as a standardized checklist.
If you or a loved one is experiencing memory concerns, the first step is scheduling an evaluation with a primary care physician or neurologist. Bring a notebook documenting when problems started, specific examples of memory lapses, and information about family history. Come prepared to discuss how these changes affect daily life—whether the person is still managing finances and medications independently, still driving safely, still engaging in hobbies. This information, combined with appropriate testing, gives doctors the foundation needed to understand what’s happening and discuss options for treatment or monitoring.
You Might Also Like
- Reversible Causes of Memory Loss Doctors May Check First
- MRI Findings That May Be Linked to Memory Loss
- Brain Volume Loss on MRI: What It May Mean for Memory
For more, see National Institute on Aging.
